RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March
In a report released today, Ben Klieve from Lake Street reiterated a Buy rating on Marrone Bio (MBII – Research Report), with a price target of $1.30. The company’s shares closed last Thursday at $1.05.
According to TipRanks.com, Klieve is ranked #403 out of 7913 analysts.
Marrone Bio has an analyst consensus of Moderate Buy, with a price target consensus of $1.88.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $2.56 and a one-year low of $0.55. Currently, Marrone Bio has an average volume of 847.3K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate and majestene. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.
Read More on MBII:
There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Marrone Bio (MBII – Research Report) and Dow Inc (DOW – Research Report) with bullish sentiments.
Marrone Bio (MBII)
In a report issued on January 19, Amit Dayal from H.C. Wainwright maintained a Buy rating on Marrone Bio, with a price target of $4.00. The company’s shares closed last Thursday at $0.67, close to its 52-week low of $0.55.
According to TipRanks.com, Dayal is a top 100 analyst with an average return of
Currently, the analyst consensus on Marrone Bio is a Moderate Buy with an average price target of $2.45.
See the top stocks recommended by analysts >>
Dow Inc (DOW)
In a report issued on January 31, Hassan Ahmed from Alembic Global reiterated a Buy rating on Dow Inc, with a price target of $85.00. The company’s shares closed last Thursday at $61.17.
According to TipRanks.com, Ahmed is a 5-star analyst with an average return of
Dow Inc has an analyst consensus of Moderate Buy, with a price target consensus of $69.31, a 13.0% upside from current levels. In a report issued on February 8, Piper Sandler also maintained a Buy rating on the stock with a $76.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MBII:
For investors seeking the strongest possible returns, there has always been a clear path. It involves risk, but the rewards are real. We’re talking, of course, about the outsized gains
H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Marrone Bio (MBII – Research Report) today and set a price target of $4.00. The company’s shares closed last Thursday at $0.88, close to its 52-week low of $0.77.
According to TipRanks.com, Dayal is a top 100 analyst with an average return of 64.1% and a 53.3% success rate. Dayal covers the Industrial Goods sector, focusing on stocks such as Capstone Green Energy, Ballard Power Systems, and Westport Fuel Systems.
Marrone Bio has an analyst consensus of Moderate Buy, with a price target consensus of $3.25, a 261.6% upside from current levels. In a report released yesterday, Lake Street also reiterated a Buy rating on the stock with a $2.50 price target.
See Insiders’ Hot Stocks on TipRanks >>
Marrone Bio’s market cap is currently $131.4M and has a P/E ratio of -7.90. The company has a Price to Book ratio of 19.84.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MBII in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate and majestene. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.
Read More on MBII: